Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Ming Meng

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Advances in Experimental Medicine and Biology|August 11, 2019
Inflammatory Mediators and Renal FibrosisXiao-Ming Meng
Sheng Li Xue Bao : [Acta Physiologica Sinica]|December 19, 2018
[Transforming growth factor-β and renal fibrosis]Xiao-Ming Meng, Hui-Yao Lan
Advances in Experimental Medicine and Biology|August 11, 2019
TGF-β/Smad and Renal FibrosisTao-Tao Ma, Xiao-Ming Meng
Frontiers in Physiology|January 24, 2022
Editorial: Epigenetic Regulation in Renal Development, Physiology and DiseaseJuan Jin, Haiyong Chen, Xiao-Ming Meng
Kidney International|May 21, 2026
The authors replyShuai-Shuai Xie, Chao Hou, Xiao-Ming Meng
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2013
IL-2 is a gradually proved potential therapeutic target for hepatocellular carcinomaTao Xu, Xiao-Ming Meng, Hong-Wei Yao, et al.
Acta Pharmacologica Sinica|December 15, 2023
Nucleic acid and protein methylation modification in renal diseasesJuan Jin, Xue-Mei Liu, Wei Shao, et al.
Nature Reviews. Nephrology|April 26, 2016
TGF-β: the master regulator of fibrosisXiao-Ming Meng, David J Nikolic-Paterson, Hui Yao Lan
Advances in Experimental Medicine and Biology|August 11, 2019
Macrophages in Renal FibrosisXiao-Ming Meng, Thomas Shiu-Kwong Mak, Hui-Yao Lan
Biochimie|June 28, 2015
Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosisPei-Jie Chen, Cheng Huang, Xiao-Ming Meng, et al.
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Advances in Experimental Medicine and Biology|August 11, 2019
Inflammatory Mediators and Renal FibrosisXiao-Ming Meng
Sheng Li Xue Bao : [Acta Physiologica Sinica]|December 19, 2018
[Transforming growth factor-β and renal fibrosis]Xiao-Ming Meng, Hui-Yao Lan
Advances in Experimental Medicine and Biology|August 11, 2019
TGF-β/Smad and Renal FibrosisTao-Tao Ma, Xiao-Ming Meng
Frontiers in Physiology|January 24, 2022
Editorial: Epigenetic Regulation in Renal Development, Physiology and DiseaseJuan Jin, Haiyong Chen, Xiao-Ming Meng
Kidney International|May 21, 2026
The authors replyShuai-Shuai Xie, Chao Hou, Xiao-Ming Meng
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2013
IL-2 is a gradually proved potential therapeutic target for hepatocellular carcinomaTao Xu, Xiao-Ming Meng, Hong-Wei Yao, et al.
Acta Pharmacologica Sinica|December 15, 2023
Nucleic acid and protein methylation modification in renal diseasesJuan Jin, Xue-Mei Liu, Wei Shao, et al.
Nature Reviews. Nephrology|April 26, 2016
TGF-β: the master regulator of fibrosisXiao-Ming Meng, David J Nikolic-Paterson, Hui Yao Lan
Advances in Experimental Medicine and Biology|August 11, 2019
Macrophages in Renal FibrosisXiao-Ming Meng, Thomas Shiu-Kwong Mak, Hui-Yao Lan
Biochimie|June 28, 2015
Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosisPei-Jie Chen, Cheng Huang, Xiao-Ming Meng, et al.
Pageof 21